STING and TLR-independent activation of T-cell responses against pancreatic cancer using agonistic CD40 antibody

被引：0
|
作者：
Byrne, Katelyn T. [1 ]
Morrison, Alexander H. [2 ]
Vonderheide, Robert H. [3 ]
机构：
[1] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA
[2] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 24期
关键词：
D O I：
10.1158/1538-7445.PANCA19-PR04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PR04
引用
收藏
页数：2
相关论文
共 50 条
  • [41] T-cell activation induced by anti-CD3 x anti-B-cell lymphoma monoclonal antibody is enhanced by pretreatment of lymphoma cells with soluble CD40 ligand
    Wooldridge, JE
    Dahle, CE
    Weiner, GJ
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1997, 45 (3-4) : 174 - 179
  • [42] B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression
    Schuster, M
    Kocher, A
    John, R
    Hoffman, M
    Ankersmit, J
    Lietz, K
    Edwards, O
    Oz, M
    Itescu, S
    HUMAN IMMUNOLOGY, 2002, 63 (03) : 211 - 220
  • [43] Induction of T-cell tolerance in a patient with idiopathic thrombocytopenic purpura by single injection of humanized monoclonal antibody to CD40 ligand
    Nomura, S
    Kuwana, M
    Yasuo, I
    AUTOIMMUNITY, 2003, 36 (05) : 317 - 319
  • [44] Induction of CD4+ T cell-independent B cell responses in vivo by CD40 ligand DNA vaccination: Implications for vaccine development
    Zheng, MQ
    Hite, F
    Steele, C
    Zhong, Q
    Julian, S
    Schwarzenberger, P
    Shellito, J
    Ramsay, AJ
    Kolls, JK
    MOLECULAR THERAPY, 2003, 7 (05) : S312 - S312
  • [45] TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation
    Bachmann, MF
    Wong, BR
    Josien, R
    Steinman, RM
    Oxenius, A
    Choi, Y
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07): : 1025 - 1031
  • [46] Doxorubicin enhances CD4+ T-cell immune responses by inducing expression of CD40 ligand and 4-1BB
    Park, Jae Yeo
    Jang, Min Ja
    Chung, Yoon Hee
    Kim, Kyung Yong
    Kim, Sung Su
    Lee, Won Bok
    You, Seungkwon
    Choi, Youn Seok
    Hur, Dae Young
    Kim, Daejin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2009, 9 (13-14) : 1530 - 1539
  • [47] HUMAN-ANTIBODY RESPONSE IN HUMAN PERIPHERAL-BLOOD LEUKOCYTE SEVERE COMBINED IMMUNODEFICIENT CHIMERIC MODEL IS DEPENDENT ON B-CELL AND T-CELL COSTIMULATION VIA CD40/CD40 LIGAND
    CHEN, FA
    WILLIAMS, SS
    FANSLOW, WC
    BANKERT, RB
    JOURNAL OF IMMUNOLOGY, 1995, 155 (06): : 2833 - 2840
  • [48] B cell immunopoiesis: visualizing the impact of CD40 engagement on the course of T cell-independent immune responses in an Ig transgenic system
    Erickson, LD
    Vogel, LA
    Cascalho, M
    Wong, J
    Wabl, M
    Durell, BG
    Noelle, RJ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2000, 30 (11) : 3121 - 3131
  • [49] Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8+ T cell responses in the absence of CD4+ T cells
    Bullock, TNJ
    Yagita, H
    JOURNAL OF IMMUNOLOGY, 2005, 174 (02): : 710 - 717
  • [50] Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy
    Wenthe, Jessica
    Naseri, Sedigheh
    Labani-Motlagh, Alireza
    Enblad, Gunilla
    Wikstrom, Kristina I.
    Eriksson, Emma
    Loskog, Angelica
    Lovgren, Tanja
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (10) : 2851 - 2865
12345